15 639
pregnancies achieved over 18 years
Moscow
Russia
+7 (800) 551-16-72

Monday - Sunday

Preimplantation Genetic Testing (PGT)

In a standard IVF treatment, every time a cycle produces more than one embryo, a choice must be made about which embryo will be transferred. That choice is determined by the development and appearance of the embryos.

However, recent scientific advances mean PGT gives us another decision-making factor - the genetic health of the embryo.

Preimplantation Genetic Screening for all 24 chromosomes

including Embryo trophectoderm biopsy and Assisted hatching
1 embryo

107 560 RUR
Preimplantation Genetic Screening for all 24 chromosomes

including Embryo trophectoderm biopsy and Assisted hatching
2 embryo

149 360 RUR
Preimplantation Genetic Screening for all 24 chromosomes

including Embryo trophectoderm biopsy and Assisted hatching
every additional embryo

22 000 RUR
PGS-24: detection of structural chromosomal abnormalities

performed for medical reasons
1 embryos

133 100 RUR
PGS-24: detection of structural chromosomal abnormalities

performed for medical reasons
every additional embryo

38 500 RUR
PGD preliminary phase
for carriers of single gene disorder, including
273 900 RUR

PGD

Pre-implantation genetic diagnosis (PGD) refers to genetic profiling of embryos created through IVF prior to the transfer into the patient’s uterus. During PGD the embryos are screened for a number of specific genetic disorders, so as to exclude the possibility of selected embryos having these particular abnormalities.

PGD enables patients with a chronic disease in their family history to avoid passing it on to their children. A specialist may recommend PGD if patients have a family history of severe genetic diseases or previous miscarriages due to genetic disorders.

PGS

The term preimplantation genetic screening (PGS) is used to denote procedures that do not look for a specific disease but use PGD techniques to identify embryos at risk. PGS involves checking the embryos chromosomes for common abnormalities. Chromosomal abnormalities are a major cause of miscarriages and the failure of embryos to implant. They can also cause such serious medical conditions as Down’s syndrome.

PGS is normally recommended for:

  • older patients ( women over 35 years old);
  • patients with a history of recurrent miscarriages;
  • patients with a history of unsuccessful IVF cycles after the embryo transfer stage;
  • patients with a family history of chromosomal diseases.
Ask a question
person_outline
Name
phone
Phone number
person_outline
E-mail
Your message
Medical team
Zarema Barakhoeva
Zarema Barakhoeva
Zarema Barakhoeva
Reproductive Endocrinologist, Gynecologist, MD, PHD
Anton Bolt
Anton Bolt
Anton Bolt
Lead Embryologist
Sergey Yakovenko
Sergey Yakovenko
Sergey Yakovenko
CEO, embryologist, PhD, Associate Professor at Moscow State University, Department of Biophysics.
Ekaterina Osina
Ekaterina Osina
Ekaterina Osina
Reproductive Endocrinologist, Gynecologist, MD
Sona Nshanyan
Sona Nshanyan
Sona Nshanyan
Reproductive Endocrinologist, Gynecologist, PHD
Riad Safi
Riad Safi
Riad Safi
Gynecologist obstetrician.
Yaroslav Lugovtsov
Yaroslav Lugovtsov
Yaroslav Lugovtsov
Ultrasonographer, MD
Aleksandra Shushkova
Aleksandra Shushkova
Aleksandra Shushkova
Reproductive Endocrinologist, Gynecologist
Margarita Kharitonova
Margarita Kharitonova
Margarita Kharitonova
Deputy Laboratory Director, PhD
Elena Meshcheryakova
Elena Meshcheryakova
Elena Meshcheryakova
Urologist, Andrologist
Make an appointment
person_outline
Name
phone
Phone
Altravita Clinic occupies leading positions in the field of reproductive medicine, the treatment of female and male infertility, cytogenetic and molecular-genetic studies.
arrow_upward